Fresenius Medical Care AG (ETR:FME – Get Free Report) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of €38.78 ($39.98) and traded as high as €44.82 ($46.21). Fresenius Medical Care shares last traded at €44.82 ($46.21), with a volume of 424,076 shares traded.
Fresenius Medical Care Stock Up 0.2 %
The firm has a market capitalization of $13.17 billion, a price-to-earnings ratio of 24.81, a P/E/G ratio of 0.42 and a beta of 0.86. The company has a current ratio of 1.46, a quick ratio of 0.80 and a debt-to-equity ratio of 77.56. The firm has a fifty day moving average price of €43.40 and a 200 day moving average price of €38.78.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Articles
- Five stocks we like better than Fresenius Medical Care
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- What is a Low P/E Ratio and What Does it Tell Investors?
- Oilfield Leader SLB: An AI Name You Need to Know
- The Most Important Warren Buffett Stock for Investors: His Own
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.